Search Results

You are looking at 1 - 10 of 168 items for :

  • Refine by Access: All x
Clear All
Full access

Outcomes of COVID-19 in Patients With a History of Cancer and Comorbid Cardiovascular Disease

Sarju Ganatra, Sourbha S. Dani, Robert Redd, Kimberly Rieger-Christ, Rushin Patel, Rohan Parikh, Aarti Asnani, Vigyan Bang, Katherine Shreyder, Simarjeet S. Brar, Amitoj Singh, Dhruv S. Kazi, Avirup Guha, Salim S. Hayek, Ana Barac, Krishna S. Gunturu, Corrine Zarwan, Anne C. Mosenthal, Shakeeb A. Yunus, Amudha Kumar, Jaymin M. Patel, Richard D. Patten, David M. Venesy, Sachin P. Shah, Frederic S. Resnic, Anju Nohria, and Suzanne J. Baron

Background COVID-19 caused by the SARS-CoV-2 virus has affected millions of people globally. Early reports have suggested that patients with advanced age and other comorbid conditions, particularly cancer and cardiovascular disease (CVD), face

Full access

Experience, Perceptions, and Recommendations Concerning COVID-19–Related Clinical Research Adjustments

David E. Gerber, Thomas Y. Sheffield, M. Shaalan Beg, Erin L. Williams, Valerie L. Clark, Yang Xie, M.E. Blair Holbein, Celette Sugg Skinner, and Simon J. Craddock Lee

In response to the COVID-19–related public health emergency, clinical research regulatory authorities have recognized the potential challenges posed by COVID-19, including site closures, travel restrictions, quarantines, investigational product

Full access

Incident Cancer Detection During Multiple Waves of COVID-19: The Tsunami After the Earthquake

Rui Fu, Rinku Sutradhar, Qing Li, Timothy P. Hanna, Kelvin K.W. Chan, Jonathan C. Irish, Natalie Coburn, Julie Hallet, Anna Dare, Simron Singh, Ambica Parmar, Craig C. Earle, Lauren Lapointe-Shaw, Monika K. Krzyzanowska, Antonio Finelli, Alexander V. Louie, Nicole J. Look Hong, Ian J. Witterick, Alyson Mahar, David Gomez, Daniel I. McIsaac, Danny Enepekides, David R. Urbach, and Antoine Eskander

As of August 29, 2022, COVID-19 has infected more than 601 million people worldwide, with the death toll exceeding 6.4 million. However, some of the devastating consequences of COVID-19 are only now emerging. Non–COVID-19 care, including cancer

Full access

Safety at the Time of the COVID-19 Pandemic: How to Keep Our Oncology Patients and Healthcare Workers Safe

Pelin Cinar, Timothy Kubal, Alison Freifeld, Asmita Mishra, Lawrence Shulman, James Bachman, Rafael Fonseca, Hope Uronis, Dori Klemanski, Kim Slusser, Matthew Lunning, and Catherine Liu

The novel coronavirus, SARS-CoV-2, was first detected as a respiratory illness in December 2019 in Wuhan City, China. Since detection, the disease caused by SARS-CoV-2, known as coronavirus disease 2019 (COVID-19), has impacted every aspect of our

Full access

Posttraumatic Stress Symptoms in Patients With Cancer During the COVID-19 Pandemic: A One-Year Longitudinal Study

Etienne Bastien, Sophie Lefèvre-Arbogast, Justine Lequesne, François Gernier, François Cherifi, Olivier Rigal, Lydia Guittet, Jean‐Michel Grellard, Giulia Binarelli, Marie Lange, Marie Fernette, Laure Tron, Adeline Morel, Doriane Richard, Bénédicte Griffon, Alexandra Leconte, Florian Quilan, Louis-Ferdinand Pépin, Fabrice Jardin, Marianne Leheurteur, Audrey Faveyrial, Bénédicte Clarisse, and Florence Joly

Background The COVID-19 pandemic spread worldwide in January 2020 and led to national measures such as lockdowns and curfews in many parts of the world as soon as March/April 2020. This stressful event has deeply and lastingly impacted

Full access

Telemedicine in Oncology and Reimbursement Policy During COVID-19 and Beyond

Sheetal M. Kircher, Mary Mulcahy, Aparna Kalyan, Christine B. Weldon, Julia R. Trosman, and Al B. Benson III

Rapid Implementation of Telemedicine in Oncology Practices The first confirmed case of coronavirus disease 2019 (COVID-19) in the United States was reported on January 20, 2020. 1 As of September 17, 2020, there were more than 6.6 million

Full access

Incident Cancer Detection During the COVID-19 Pandemic

Antoine Eskander, Qing Li, Jiayue Yu, Julie Hallet, Natalie G. Coburn, Anna Dare, Kelvin K.W. Chan, Simron Singh, Ambica Parmar, Craig C. Earle, Lauren Lapointe-Shaw, Monika K. Krzyzanowska, Timothy P. Hanna, Antonio Finelli, Alexander V. Louie, Nicole Look Hong, Jonathan C. Irish, Ian J. Witterick, Alyson Mahar, Christopher W. Noel, David R. Urbach, Daniel I. McIsaac, Danny Enepekides, and Rinku Sutradhar

place during the COVID-19 pandemic. 3 – 8 Disruption to healthcare access may negatively impact early detection of cancers and lead to a spurious decline in observed cancer incidence. Some countries observed a decrease in incidence rates during the

Full access

Immune-Related Adverse Events Among COVID-19–Vaccinated Patients With Cancer Receiving Immune Checkpoint Blockade

Adam J. Widman, Bevin Cohen, Vivian Park, Tara McClure, Jedd Wolchok, and Mini Kamboj

Background Recently introduced vaccines for COVID-19 are a critical advance against the COVID-19 pandemic. 1 , 2 The postvaccine reduction in COVID-19–related hospitalization heralds the immense promise of these tools to reduce the impact of

Full access

Adverse Events Reported by Patients With Cancer After Administration of a 2-Dose mRNA COVID-19 Vaccine

Rebecca M. Shulman, David S. Weinberg, Eric A. Ross, Karen Ruth, Glenn F. Rall, Anthony J. Olszanski, James Helstrom, Michael J. Hall, Julia Judd, David Y.T. Chen, Robert G. Uzzo, Timothy P. Dougherty, Riley Williams, Daniel M. Geynisman, Carolyn Y. Fang, Richard I. Fisher, Marshall Strother, Erica Huelsmann, Sunil Adige, Peter D. Whooley, Kevin Zarrabi, Brinda Gupta, Pritish Iyer, Melissa McShane, Hilario Yankey, Charles T. Lee, Nina Burbure, Lauren E. Laderman, Julie Giurintano, Samuel Reiss, and Eric M. Horwitz

Background More than 338 million doses of the COVID-19 vaccine were administered in the United States from December 2020 to July 2021. This far-reaching public health initiative generated 5,325 reports of vaccine-related deaths. 1 , 2 Although

Full access

Cancer Treatment During COVID-19: Resilience of Individuals With Advanced Non–Small Cell Lung Cancer Versus Community Controls

Nicole A. Arrato, Stephen B. Lo, Clarence A. Coker, Jonathan J. Covarrubias, Tessa R. Blevins, Sarah A. Reisinger, Carolyn J. Presley, Peter G. Shields, and Barbara L. Andersen

Background Patients with cancer are more vulnerable to COVID-19 than otherwise healthy individuals. Patients with lung cancer (LC) are uniquely vulnerable to coronaviral pneumonias (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2